A Generalized Physiologically Based Kinetic Model for Fish for Environmental Risk Assessment of Pharmaceuticals
- PMID: 35472258
- PMCID: PMC9118555
- DOI: 10.1021/acs.est.1c08068
A Generalized Physiologically Based Kinetic Model for Fish for Environmental Risk Assessment of Pharmaceuticals
Abstract
An increasing number of pharmaceuticals found in the environment potentially impose adverse effects on organisms such as fish. Physiologically based kinetic (PBK) models are essential risk assessment tools, allowing a mechanistic approach to understanding chemical effects within organisms. However, fish PBK models have been restricted to a few species, limiting the overall applicability given the countless species. Moreover, many pharmaceuticals are ionizable, and fish PBK models accounting for ionization are rare. Here, we developed a generalized PBK model, estimating required parameters as functions of fish and chemical properties. We assessed the model performance for five pharmaceuticals (covering neutral and ionic structures). With biotransformation half-lives (HLs) from EPI Suite, 73 and 41% of the time-course estimations were within a 10-fold and a 3-fold difference from measurements, respectively. The performance improved using experimental biotransformation HLs (87 and 59%, respectively). Estimations for ionizable substances were more accurate than any of the existing species-specific PBK models. The present study is the first to develop a generalized fish PBK model focusing on mechanism-based parameterization and explicitly accounting for ionization. Our generalized model facilitates its application across chemicals and species, improving efficiency for environmental risk assessment and supporting an animal-free toxicity testing paradigm.
Keywords: fish; internal concentrations; ionization; pharmaceuticals; physiologically based kinetic model.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
References
-
- OECD , Health at a Glance 2017. 2017. Place.
-
- Boxall A. B.; Rudd M. A.; Brooks B. W.; Caldwell D. J.; Choi K.; Hickmann S.; Innes E.; Ostapyk K.; Staveley J. P.; Verslycke T.; Ankley G. T.; Beazley K. F.; Belanger S. E.; Berninger J. P.; Carriquiriborde P.; Coors A.; DeLeo P. C.; Dyer S. D.; Ericson J. F.; Gagné F.; Giesy J. P.; Gouin T.; Hallstrom L.; Karlsson M. V.; Larsson D. G. J.; Lazorchak J. M.; Mastrocco F.; McLaughlin A.; McMaster M. E.; Meyerhoff R. D.; Moore R.; Parrott J. L.; Snape J. R.; Murray-Smith R.; Servos M. R.; Sibley P. K.; Straub J. O.; Szabo N. D.; Topp E.; Tetreault G. R.; Trudeau V. L.; van der Kraak G. Pharmaceuticals and personal care products in the environment: what are the big questions?. Environ. Health Perspect. 2012, 120, 1221–1229. 10.1289/ehp.1104477. - DOI - PMC - PubMed
-
- Meyer M. F.; Powers S. M.; Hampton S. E. An evidence synthesis of pharmaceuticals and personal care products (PPCPs) in the environment: imbalances among compounds, sewage treatment techniques, and ecosystem types. Environ. Sci. Technol. 2019, 53, 12961–12973. 10.1021/acs.est.9b02966. - DOI - PubMed
-
- Tanoue R.; Nomiyama K.; Nakamura H.; Kim J.-W.; Isobe T.; Shinohara R.; Kunisue T.; Tanabe S. Uptake and tissue distribution of pharmaceuticals and personal care products in wild fish from treated-wastewater-impacted streams. Environ. Sci. Technol. 2015, 49, 11649–11658. 10.1021/acs.est.5b02478. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
